SEC Comment Letter 0000000000-23-012475 to SpringWorks Therapeutics, Inc. (SWTX) (CIK 0001773427)
SpringWorks Therapeutics, Inc. (SWTX) (CIK 0001773427)
Date: Nov. 14, 2023 · CIK: 0001773427 · Accession: 0000000000-23-012475
AI Filing Summary & Sentiment
File numbers found in text: 001-39044
Letter
United States securities and exchange commission logo November 14, 2023 Saqib Islam Chief Executive Officer SpringWorks Therapeutics, Inc. 100 Washington Blvd Stamford, CT 06902 Re:SpringWorks Therapeutics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Filed February 28, 2023 File No. 001-39044 Dear Saqib Islam: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
November 14, 2023
Saqib Islam
Chief Executive Officer
SpringWorks Therapeutics, Inc.
100 Washington Blvd
Stamford, CT 06902
Re:SpringWorks Therapeutics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2022
Filed February 28, 2023
File No. 001-39044
Dear Saqib Islam:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences